Status:
COMPLETED
A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Influenza
Eligibility:
All Genders
1+ years
Phase:
PHASE4
Brief Summary
This 2 arm study will evaluate the efficacy and safety of oseltamivir in the seasonal prophylaxis of influenza in immunocompromised participants (as represented by transplant recipients). Transplant r...
Eligibility Criteria
Inclusion
- Negative rapid diagnostic test for influenza at baseline;
- Immunocompromised participant (liver and/or kidney recipient or allogenic hematopoietic stem cell transplant).
Exclusion
- Symptoms suggestive of influenza-like illness; but not limited to fever, cough, or nasal congestion;
- Influenza vaccination in 6 weeks prior to randomization;
- Positive rapid diagnostic test for influenza;
- Solid organ transplant within 6 months of randomization;
- Antiviral treatment for influenza in 2 weeks prior to randomization.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT00412737
Start Date
January 1 2007
End Date
May 1 2008
Last Update
June 10 2016
Active Locations (78)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35233
2
Little Rock, Arkansas, United States, 72202
3
Stanford, California, United States, 94305
4
Denver, Colorado, United States, 80262